Dr. Deuchars is Senior Manager, Business Development and Research, at Ontario Genomics, where she works to facilitate genomic innovation in health care. Dr. Deuchars has over twenty years of experience in the field of biotechnology innovation, venture financing and health technology commercialization. She is also Director of the Ontario Personalized Medicine Network, a stakeholder volunteer group formed to enable the adoption of personalized medicine technologies in Ontario to improve health.
Previously Dr. Deuchars was President and CEO of Light Matter Interaction (formerly Attodyne Inc.), a Toronto start-up medical/industrial device company. Before that Dr. Deuchars focused on the venture financing of early-stage biomedical innovations as Chief Operating Officer of University Medical Discoveries as well as on later stage investment opportunities for Lumira Capital (formerly MDS Capital). Dr. Deuchars also spent six years in the biotechnology industrial sector as a research scientist at NPS Allelix Inc.
Dr. Deuchars earned her Master’s and PhD degrees from the University of Toronto, and an Hon. B.Sc. from Western University.